SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.

Gierula, M; Salles-Crawley, II; Santamaria, S; Teraz-Orosz, A; Crawley, JTB; Lane, DA; Ahnström, J (2019) The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex. J Thromb Haemost, 17 (12). pp. 2056-2068. ISSN 1538-7836 https://doi.org/10.1111/jth.14594
SGUL Authors: Salles-Crawley, Isabelle Irene

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img]
Preview
PDF (Supporting Information) Published Version
Available under License Creative Commons Attribution.

Download (168kB) | Preview

Abstract

BACKGROUND: Activated protein C (APC)-mediated inactivation of factor (F)Va is greatly enhanced by protein S. For inactivation to occur, a trimolecular complex among FVa, APC, and protein S must form on the phospholipid membrane. However, direct demonstration of complex formation has proven elusive. OBJECTIVES: To elucidate the nature of the phospholipid-dependent interactions among APC, protein S, and FVa. METHODS: We evaluated binding of active site blocked APC to phospholipid-coated magnetic beads in the presence and absence of protein S and/or FVa. The importance of protein S and FV residues were evaluated functionally. RESULTS: Activated protein C alone bound weakly to phospholipids. Protein S mildly enhanced APC binding to phospholipid surfaces, whereas FVa did not. However, FVa together with protein S enhanced APC binding (>14-fold), demonstrating formation of an APC/protein S/FVa complex. C4b binding protein-bound protein S failed to enhance APC binding, agreeing with its reduced APC cofactor function. Protein S variants (E36A and D95A) with reduced APC cofactor function exhibited essentially normal augmentation of APC binding to phospholipids, but diminished APC/protein S/FVa complex formation, suggesting involvement in interactions dependent upon FVa. Similarly, FVaNara (W1920R), an APC-resistant FV variant, also did not efficiently incorporate into the trimolecular complex as efficiently as wild-type FVa. FVa inactivation assays suggested that the mutation impairs its affinity for phospholipid membranes and with protein S within the complex. CONCLUSIONS: FVa plays a central role in the formation of its inactivation complex. Furthermore, membrane proximal interactions among FVa, APC, and protein S are essential for its cofactor function.

Item Type: Article
Additional Information: © 2019 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: activated protein C, factor Va, phopsholipids, protein S, prothrombinase, Binding Sites, Blood Coagulation, Calcium-Binding Proteins, Enzyme Activation, Factor Va, HEK293 Cells, Humans, Models, Molecular, Multiprotein Complexes, Phospholipids, Protein Binding, Protein C, Protein Conformation, Protein S, Structure-Activity Relationship, Thrombin, Thromboplastin, Humans, Multiprotein Complexes, Protein C, Thrombin, Phospholipids, Factor Va, Thromboplastin, Protein S, Calcium-Binding Proteins, Binding Sites, Enzyme Activation, Protein Conformation, Protein Binding, Structure-Activity Relationship, Blood Coagulation, Models, Molecular, HEK293 Cells, activated protein C, factor Va, phopsholipids, protein S, prothrombinase, Cardiovascular System & Hematology, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: J Thromb Haemost
ISSN: 1538-7836
Language: eng
Dates:
DateEvent
2 December 2019Published
9 August 2019Published Online
26 July 2019Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
PG/14/90/31219British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/14/63/31036British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
FS/10/004/28165British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PG/17/42/33039British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
FS/12/60/29874British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
RG/18/3/33405British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PubMed ID: 31364267
Web of Science ID: WOS:000481193200001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114223
Publisher's version: https://doi.org/10.1111/jth.14594

Actions (login required)

Edit Item Edit Item